Cargando…
High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer
BACKGROUND: Transmembrane protein 180 (TMEM180) is a newly identified colorectal cancer (CRC)-specific molecule that is expressed very rarely in normal tissue and up-regulated under hypoxic conditions. We developed a monoclonal antibody (mAb) against TMEM180 and decided to examine the medical signif...
Autores principales: | Shiraishi, Takuya, Ikeda, Koji, Tsukada, Yuichiro, Nishizawa, Yuji, Sasaki, Takeshi, Ito, Masaaki, Kojima, Motohiro, Ishii, Genichiro, Tsumura, Ryo, Saijou, Sinji, Koga, Yoshikatsu, Yasunaga, Masahiro, Matsumura, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989078/ https://www.ncbi.nlm.nih.gov/pubmed/33757462 http://dx.doi.org/10.1186/s12885-021-08046-6 |
Ejemplares similares
-
Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer‐specific molecule
por: Yasunaga, Masahiro, et al.
Publicado: (2019) -
TMEM180 contributes to SW480 human colorectal cancer cell proliferation through intra-cellular metabolic pathways
por: Anzai, Takahiro, et al.
Publicado: (2021) -
Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models
por: Tsumura, Ryo, et al.
Publicado: (2019) -
Risk factors for parastomal hernia of loop stoma and relationships with other stoma complications in laparoscopic surgery era
por: Shiraishi, Takuya, et al.
Publicado: (2020) -
Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer
por: Shiraishi, Takuya, et al.
Publicado: (2019)